
Nalkem Pharmaceuticals India Private Limited
Pharmaceutical trading company based in Hyderabad, established in 2019.
Pharmaceutical trading company based in Hyderabad, established in 2019.
Nalkem Pharmaceuticals India Private Limited (NPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 2019 (Five years and five months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Sridev Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jaya Nalla, Keerthi Katta, Rajee Nalla, and One other member serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U33208TG2019PTC137114
137114
Private Limited Indian Non-Government Company
25 Nov 2019
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jaya Nalla ![]() | Additional Director | 17-Jun-2024 | Current |
Keerthi Katta ![]() | Director | 25-Nov-2019 | Current |
Rajee Nalla ![]() | Director | 16-Oct-2020 | Current |
Venkata Lakkimsetty ![]() | Additional Director | 17-Jun-2024 | Current |
Nalkem Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.75% decrease. The company also saw a substantial improvement in profitability, with a 100.37% increase in profit. The company's net worth moved up by a moderate rise of 0.2%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Nalkem Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Jaya Nalla is a mutual person
Jaya Nalla and Venkata Lakkimsetty are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nalkem Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nalkem Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nalkem Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nalkem Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Jaya Bhanu Venkata Nageswara Rao Nalla was appointed as a Additional Director was appointed as a Additional Director on 17 Jun 2024 & has been associated with this company since 10 months 23 days .
Venkata Laxmi Lakkimsetty was appointed as a Additional Director was appointed as a Additional Director on 17 Jun 2024 & has been associated with this company since 10 months 23 days .
Nalkem Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Rajee Dakshayani Nalla was appointed as a Director was appointed as a Director on 16 Oct 2020 & has been associated with this company since 4 years 6 months .
Keerthi Priyanka Katta was appointed as a Director was appointed as a Director on 25 Nov 2019 & has been associated with this company since 5 years 5 months .
Nalkem Pharmaceuticals India Private Limited was incorporated on 25 Nov 2019.
The authorized share capital of Nalkem Pharmaceuticals India Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 5.00 M.
Currently 4 directors are associated with Nalkem Pharmaceuticals India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Nalkem Pharmaceuticals India Private Limited is Plot No 83/B2 1St Floor Phase-1 Road No.18 Ida, Jeedimetla India, Hyderabad, Telangana, 500055.
The corporate identification number (CIN) of Nalkem Pharmaceuticals India Private Limited is U33208TG2019PTC137114 and the company number is 137114 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Nalkem Pharmaceuticals India Private Limited has fallen by -97.75%.
The financial reports for the fiscal year 2023 indicates that The net worth of Nalkem Pharmaceuticals India Private Limited has experienced an upsurge of 0.20%.
The most recent Balance Sheet for Nalkem Pharmaceuticals India Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
RB